1. 1319PPost-hoc analysis of CLARINET phase III study to investigate the influence of diabetic status on progression-free survival (PFS) of patients with neuroendocrine tumours (NETs) treated with lanreotide (LAN) or placebo (PBO). (23rd October 2018) Authors: Pusceddu, S; Vernieri, C; Di Maio, M; Prinzi, N; Torchio, M; Buzzoni, R; Truong-Thanh, X-M; Mazzaferro, V; de Braud, F G M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1308OActivity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx). (23rd October 2018) Authors: Yao, J C; Strosberg, J; Fazio, N; Pavel, M E; Ruszniewski, P; Bergsland, E; Li, D; Tafuto, S; Raj, N; Campana, D; Hijioka, S; Raderer, M; Guimbaud, R; Gajate, P; Pusceddu, S; Reising, A; Degtyarev, E; Mookerjee, B; Aimone, P; Singh, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1324PThe role of modulation of somatostatin analogues (SSAs) in association to peptide receptor radionuclide therapy (PRRT) after SSAs progression disease (PD) in advanced well-differentiated (WD) entero-pancreatic neuroendocrine tumours (EP-NETs). (23rd October 2018) Authors: Prinzi, N; Seregni, E; Raimondi, A; Maccauro, M; Corti, F; Lo Russo, G; Nichetti, F; Torchio, M; Coppa, J; Peverelli, G; Pagani, F; Di Bartolomeo, M; Mazzaferro, V; de Braud, F; Pusceddu, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinico–pathological features, treatments and survival of malignant insulinomas: a multicenter study. Issue 4 (April 2020) Authors: Veltroni, A; Cosaro, E; Spada, F; Fazio, N; Faggiano, A; Colao, A; Pusceddu, S; Zatelli, M C; Campana, D; Piovesan, A; Pia, A; Grossrubatscher, E M; Filice, A; Bianchi, A; Razzore, P; Toaiari, M; Cingarlini, S; Landoni, L; Micciolo, R; Davì, M V Journal: European journal of endocrinology Issue: Volume 182:Issue 4(2020) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinico–pathological features, treatments and survival of malignant insulinomas: a multicenter study. Issue 4 (April 2020) Authors: Veltroni, A; Cosaro, E; Spada, F; Fazio, N; Faggiano, A; Colao, A; Pusceddu, S; Zatelli, M C; Campana, D; Piovesan, A; Pia, A; Grossrubatscher, E M; Filice, A; Bianchi, A; Razzore, P; Toaiari, M; Cingarlini, S; Landoni, L; Micciolo, R; Davì, M V Journal: European journal of endocrinology Issue: Volume 182:Issue 4(2020) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗